Your browser doesn't support javascript.
loading
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response.
Walker, Adam J; Mohebbi, Mohammadreza; Maes, Michael; Berk, Michael; Walder, Ken; Bortolasci, Chiara C; Liu, Zoe Sj; Ng, Chee H; Ashton, Melanie M; Berk, Lesley; Singh, Ajeet B; Malhi, Gin S; Dean, Olivia M.
Afiliación
  • Walker AJ; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Mohebbi M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Maes M; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia.
  • Berk M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Walder K; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Bortolasci CC; Department of Psychiatry, Medical University of Plodiv, Plodiv, Bulgaria.
  • Liu ZS; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Ng CH; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.
  • Ashton MM; Department of Psychiatry, University of Melbourne, Parkville, Australia.
  • Berk L; Orygen, National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Singh AB; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Malhi GS; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Dean OM; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.
Brain Behav Immun Health ; 27: 100581, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36632339

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Brain Behav Immun Health Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Brain Behav Immun Health Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos